Catalyst
Slingshot members are tracking this event:
Crinetics (CRNX) Expects to Initiate Phase 1 of CRN02481 For the Treatment of Hyperinsulinemia in 1H 2019
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CRNX | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 21, 2019
Occurred Source:
http://ir.crinetics.com/news-releases/news-release-details/crinetics-pharmaceuticals-initiates-phase-1-study-crn01941
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Hyperinsulinemia, Crn02481
